Market assessment for an innovative handheld device with applications in development of medication for neuromotor impairments

对创新手持设备在神经运动障碍药物开发中的应用的市场评估

• 批准号: 700263
• 金额: $ 2.82万
• 依托单位: MANUS NEURODYNAMICA LTD
• 依托单位国家: 英国
• 项目类别: GRD Proof of Market
• 财政年份: 2013
• 资助国家: 英国
• 起止时间: 2013 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=700263
• 关键词: Market; assessment; innovative; handheld; device

Manus Neurodynamica Ltd has developed an innovative sensor technology, integrated with adigital pen, from which a number of products could be developed. The first product group(Clinical applications) are in the diagnosis and treatment of neuromotor disorders, such asParkinson’s disease (PD) and stroke by clinicians within various levels of healthcare. Thesecond product group (Research applications) are early market segments for use of thetechnology outside of the clinic. This includes use in (a) drug development and (b) academic research into neurophysiology. Market entry for this product Group 2 may be possible, potentially before market entry of Group 1 products.Whilst from a technical perspective the technology that has been developed with four world class academic groups appears to function well and is producing promising clinical results, there are barriers to market entry and uncertainties regarding the required business strategies. The nature of the market will be explored to help finalise the business strategy.

Manus Neurodynamica Ltd 开发了一种与数字笔集成的创新传感器技术，由此可以开发出多种产品（临床应用），用于诊断和治疗神经运动疾病，例如帕金森病 (PD)。第二个产品组（研究应用）是在临床之外使用该技术的早期细分市场，其中包括（a）药物开发和（b）神经生理学市场的学术研究。该产品有可能进入第 2 组产品市场，可能先于第 1 组产品进入市场。虽然从技术角度来看，与四个世界级学术团体共同开发的技术似乎运行良好，并正在产生有希望的临床结果，但仍存在障碍市场进入和所需业务策略的不确定性将被探索，以帮助最终确定业务策略。